Suppr超能文献

白癜风患者的慢性病。一项病例对照研究。

Chronic diseases among vitiligo patients. A case control study.

作者信息

Al Houssien Abdullah O, Al Houssien Rana O, Al Ajroush Waleed, Al Kahtani Hassan S

机构信息

King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia. E-mail.

出版信息

Saudi Med J. 2017 Apr;38(4):400-404. doi: 10.15537/smj.2017.4.17551.

Abstract

To identify the proportion and risk of chronic diseases in vitiligo patients in a tertiary hospital in Riyadh, Kingdom of Saudi Arabia (KSA). Methods: A retrospective case-control study included 61 vitiligo patients and 61 normal non-dermatology controls in King Abdulaziz Medical City, Riyadh, KSA between January and September 2016. Age, gender and  co-morbid diseases including hypertension, diabetes, dyslipidemia, obesity and hypothyroidism were retrieved from participants' charts and medical records. Proportion and mean were used to describe the variables, and odds ratio (OR) was used to test the data. Results: A total of 122 participants (34 males, 88 females) equally divided in cases and controls. The mean age was 45±19 years for the case and 40±17 years for the control group. The proportion of diabetes (51%) was higher in the case group than the control (33%) (OR: 0.47; 95% confidence interval [CI]: 0.23-0.98; p=0.04). Dyslipidemia was significantly associated with vitiligo (67%) compared with the control group (48%) (OR: 0.44; 95% CI: 0.21-0.92; p=0.03). Vitiligo participants had a significantly increased risk of having hypothyroidism (26%) compared with the control group (10%) (OR: 0.31; 95% CI: 0.11-0.85; p=0.02). Conclusion: There is an increased risk of chronic diseases among vitiligo patients including diabetes, dyslipidemia, hypothyroidism, renal injuries, and obesity.

摘要

为确定沙特阿拉伯王国利雅得一家三级医院白癜风患者的慢性病比例及风险。方法:一项回顾性病例对照研究纳入了2016年1月至9月期间在沙特阿拉伯王国利雅得阿卜杜勒阿齐兹国王医疗城的61例白癜风患者和61名非皮肤科正常对照者。从参与者的病历和医疗记录中获取年龄、性别以及包括高血压、糖尿病、血脂异常、肥胖和甲状腺功能减退在内的合并疾病信息。用比例和均值描述变量,用比值比(OR)检验数据。结果:共有122名参与者(34名男性,88名女性),病例组和对照组人数相等。病例组的平均年龄为45±19岁,对照组为40±17岁。病例组糖尿病的比例(51%)高于对照组(33%)(OR:0.47;95%置信区间[CI]:0.23 - 0.98;p = 0.04)。与对照组(48%)相比,血脂异常与白癜风显著相关(67%)(OR:0.44;95% CI:0.21 -

0.92;p = 0.03)。与对照组(10%)相比,白癜风患者患甲状腺功能减退的风险显著增加(26%)(OR:0.31;95% CI:0.11 - 0.85;p = 0.02)。结论:白癜风患者患糖尿病、血脂异常、甲状腺功能减退、肾损伤和肥胖等慢性病的风险增加。

相似文献

1
Chronic diseases among vitiligo patients. A case control study.
Saudi Med J. 2017 Apr;38(4):400-404. doi: 10.15537/smj.2017.4.17551.
2
Dyslipidemia in granuloma annulare: a case-control study.
Arch Dermatol. 2012 Oct;148(10):1131-6. doi: 10.1001/archdermatol.2012.1381.
7
Quality of life in vitiligo patients in central Saudi Arabia.
Saudi Med J. 2021 Jun;42(6):682-687. doi: 10.15537/smj.2021.42.6.20200833.
9
Prevalence of sleep duration among Saudi adults.
Saudi Med J. 2017 Mar;38(3):276-283. doi: 10.15537/smj.2017.3.17101.
10
Association of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects.
Diabetes Metab Syndr. 2017 Jan-Mar;11(1):37-41. doi: 10.1016/j.dsx.2016.07.004. Epub 2016 Jul 21.

引用本文的文献

1
3
Updates on the Association Between Vitiligo and Thyroid Diseases: A Systematic Review.
Cureus. 2024 Sep 19;16(9):e69697. doi: 10.7759/cureus.69697. eCollection 2024 Sep.
4
Risk factors for cardiovascular diseases in patients with vitiligo: an analysis of current evidence.
Ann Med. 2024 Dec;56(1):2326297. doi: 10.1080/07853890.2024.2326297. Epub 2024 Sep 19.
6
Circadian clock gene expression and polymorphism in non-segmental vitiligo.
Mol Biol Rep. 2024 Jan 18;51(1):142. doi: 10.1007/s11033-023-09109-6.
7
Vitiligo and Metabolic Syndrome: Systematic Review and Meta-Analysis.
JMIR Dermatol. 2022 Mar 16;5(1):e34772. doi: 10.2196/34772.
8
deficiency in CD8 T cells ameliorates non-segmental vitiligo by reducing interferon-γ and Granzyme B.
Front Immunol. 2023 May 3;14:1158883. doi: 10.3389/fimmu.2023.1158883. eCollection 2023.
10
Vitiligo and Rise in Blood Pressure - a Case-Control Study in a Referral Dermatology Clinic in Southern Iran.
Clin Cosmet Investig Dermatol. 2020 Jun 22;13:425-430. doi: 10.2147/CCID.S257022. eCollection 2020.

本文引用的文献

1
Prevalence of vitiligo and associated comorbidities in Korea.
Yonsei Med J. 2015 May;56(3):719-25. doi: 10.3349/ymj.2015.56.3.719.
2
Vitiligo.
Lancet. 2015 Jul 4;386(9988):74-84. doi: 10.1016/S0140-6736(14)60763-7. Epub 2015 Jan 15.
3
Increased prevalence of thyroid dysfunction and diabetes mellitus in Indian vitiligo patients: A case-control study.
Indian Dermatol Online J. 2014 Oct;5(4):456-60. doi: 10.4103/2229-5178.142493.
4
The utility of dermoscopy in the diagnosis of evolving lesions of vitiligo.
Indian J Dermatol Venereol Leprol. 2014 Nov-Dec;80(6):505-8. doi: 10.4103/0378-6323.144144.
5
Psychiatric morbidity and quality of life in vitiligo patients.
Indian J Psychol Med. 2014 Jul;36(3):302-3. doi: 10.4103/0253-7176.135385.
7
Consanguinity pattern and heritability of Vitiligo in Arar, Saudi Arabia.
J Family Community Med. 2014 Jan;21(1):13-6. doi: 10.4103/2230-8229.128767.
8
Comorbidities associated with vitiligo: a ten-year retrospective study.
Dermatology. 2013;227(4):311-5. doi: 10.1159/000354607. Epub 2013 Oct 4.
9
Quality of life in family members of vitiligo patients: a questionnaire study in Saudi Arabia.
Am J Clin Dermatol. 2013 Dec;14(6):489-95. doi: 10.1007/s40257-013-0037-5.
10
Guidelines for the diagnosis and treatment of vitiligo in Japan.
J Dermatol. 2013 May;40(5):344-54. doi: 10.1111/1346-8138.12099. Epub 2013 Feb 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验